FMNL2 destabilises COMMD10 to activate NF-κB pathway in invasion and metastasis of colorectal cancer

por Yang, S S, Li, X M, Yang, M, Ren, X L, Hu, J L, Zhu, X H, Wang, F F, Zeng, Z C, Li, J Y, Cheng, Z Q, Liao, W T, Ding, Y Q, Guan, J, Liang, L
Publicado 2017

MDM2 promotes epithelial–mesenchymal transition and metastasis of ovarian cancer SKOV3 cells

por Chen, Ying, Wang, Dan-Dan, Wu, Ye-Ping, Su, Dan, Zhou, Tian-Yi, Gai, Ren-Hua, Fu, Ying-Ying, Zheng, Lin, He, Qiao-Jun, Zhu, Hong, Yang, Bo
Publicado 2017

Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer

por Yuan, Zixu, Baker, Kelsey, Redman, Mary W, Wang, Lei, Adams, Scott V, Yu, Ming, Dickinson, Brandon, Makar, Karen, Ulrich, Neli, Böhm, Jürgen, Wurscher, Michelle, Westerhoff, Maria, Medwell, Steve, Moonka, Ravi, Sinanan, Mika, Fichera, Alessandro, Vickers, Kathy, Grady, William M
Publicado 2017

Albumin, bilirubin, uric acid and cancer risk: results from a prospective population-based study

por Kühn, Tilman, Sookthai, Disorn, Graf, Mirja E, Schübel, Ruth, Freisling, Heinz, Johnson, Theron, Katzke, Verena, Kaaks, Rudolf
Publicado 2017

Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer

por Sclafani, Francesco, Brown, Gina, Cunningham, David, Wotherspoon, Andrew, Mendes, Larissa Sena Teixeira, Balyasnikova, Svetlana, Evans, Jessica, Peckitt, Clare, Begum, Ruwaida, Tait, Diana, Tabernero, Josep, Glimelius, Bengt, Roselló, Susana, Thomas, Janet, Oates, Jacqui, Chau, Ian
Publicado 2017

Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy

por Braadland, Peder R, Giskeødegård, Guro, Sandsmark, Elise, Bertilsson, Helena, Euceda, Leslie R, Hansen, Ailin F, Guldvik, Ingrid J, Selnæs, Kirsten M, Grytli, Helene H, Katz, Betina, Svindland, Aud, Bathen, Tone F, Eri, Lars M, Nygård, Ståle, Berge, Viktor, Taskén, Kristin A, Tessem, May-Britt
Publicado 2017

Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival

por Morales-Oyarvide, Vicente, Rubinson, Douglas A, Dunne, Richard F, Kozak, Margaret M, Bui, Justin L, Yuan, Chen, Qian, Zhi Rong, Babic, Ana, Da Silva, Annacarolina, Nowak, Jonathan A, Khalaf, Natalia, Brais, Lauren K, Welch, Marisa W, Zellers, Caitlin L, Ng, Kimmie, Chang, Daniel T, Miksad, Rebecca A, Bullock, Andrea J, Tseng, Jennifer F, Swanson, Richard S, Clancy, Thomas E, Linehan, David C, Findeis-Hosey, Jennifer J, Doyle, Leona A, Hornick, Jason L, Ogino, Shuji, Fuchs, Charles S, Hezel, Aram F, Koong, Albert C, Wolpin, Brian M
Publicado 2017

Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors

por Ajani, Jaffer A, Estrella, Jeannelyn S, Chen, Qiongrong, Correa, Arlene M, Ma, Lang, Scott, Ailing W, Jin, Jiankang, Liu, Bin, Xie, Min, Sudo, Kazuki, Shiozaki, Hironori, Badgwell, Brian, Weston, Brian, Lee, Jeffrey H, Bhutani, Manoop S, Onodera, Hisashi, Suzuki, Koyu, Suzuki, Akihiro, Ding, Sheng, Hofstetter, Wayne L, Johnson, Randy L, Bresalier, Robert S, Song, Shumei
Publicado 2018

Bone marrow-derived mesenchymal stromal cells promote colorectal cancer cell death under low-dose irradiation

por Feng, Hao, Zhao, Jing-kun, Schiergens, Tobias S, Wang, Pu-xiongzhi, Ou, Bao-chi, Al-Sayegh, Rami, Li, Ming-lun, Lu, Ai-guo, Yin, Shuai, Thasler, Wolfgang E
Publicado 2018

S-1 chemotherapy and intensity-modulated radiotherapy after D1/D2 lymph node dissection in patients with node-positive gastric cancer: a phase I/II study

por Wang, X, Zhao, D B, Yang, L, Chi, Y, Tang, Y, Li, N, Wang, S L, Song, Y W, Liu, Y P, Liu, W Y, Ren, H, Zhang, T, Wang, J Y, Chen, X S, Fang, H, Wang, W H, Li, Y X, Jin, J
Publicado 2018

Protein kinase D1 regulates subcellular localisation and metastatic function of metastasis-associated protein 1

por Ganju, Aditya, Chauhan, Subhash C, Hafeez, Bilal Bin, Doxtater, Kyle, Tripathi, Manish K, Zafar, Nadeem, Yallapu, Murali M, Kumar, Rakesh, Jaggi, Meena
Publicado 2018

Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota

por Goedert, James J, Hua, Xing, Bielecka, Agata, Okayasu, Isao, Milne, Ginger L, Jones, Gieira S, Fujiwara, Mutsunori, Sinha, Rashmi, Wan, Yunhu, Xu, Xia, Ravel, Jacques, Shi, Jianxin, Palm, Noah W, Feigelson, Heather Spencer
Publicado 2018

H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma

por Zhang, Wenyan, Duan, Rui, Zhang, Jian, Cheung, William K C, Gao, Xiaoge, Zhang, Raymond, Zhang, Qing, Wei, Mengxue, Wang, Gang, Zhang, Qian, Mei, Peng-jin, Chen, Hong-lin, Kung, Hsiangfu, Lin, Marie C, Shen, Zan, Zheng, Junnian, Zhang, Longzhen, Yao, Hong
Publicado 2018

WNT5A induces castration-resistant prostate cancer via CCL2 and tumour-infiltrating macrophages

por Lee, Geun Taek, Kwon, Seok Joo, Kim, Jongmyung, Kwon, Young Suk, Lee, Nara, Hong, Jeong Hee, Jamieson, Christina, Kim, Wun-Jae, Kim, Isaac Yi
Publicado 2018

Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)

por Han, Baohui, Li, Kai, Zhao, Yizhuo, Li, Baolan, Cheng, Ying, Zhou, Jianying, Lu, You, Shi, Yuankai, Wang, Zhehai, Jiang, Liyan, Luo, Yi, Zhang, Yiping, Huang, Cheng, Li, Qiang, Wu, Guoming
Publicado 2018

Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study

por Lau, David K., Tay, Rebecca Y., Yeung, Yvonne H., Chionh, Fiona, Mooi, Jennifer, Murone, Carmel, Skrinos, Effie, Price, Timothy J., Mariadason, John M., Tebbutt, Niall C.
Publicado 2018

The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma

por Polena, Helena, Creuzet, Julie, Dufies, Maeva, Sidibé, Adama, Khalil-Mgharbel, Abir, Salomon, Aude, Deroux, Alban, Quesada, Jean-Louis, Roelants, Caroline, Filhol, Odile, Cochet, Claude, Blanc, Ellen, Ferlay-Segura, Céline, Borchiellini, Delphine, Ferrero, Jean-Marc, Escudier, Bernard, Négrier, Sylvie, Pages, Gilles, Vilgrain, Isabelle
Publicado 2018

A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for person...

por Herfs, Michael, Roncarati, Patrick, Koopmansch, Benjamin, Peulen, Olivier, Bruyere, Diane, Lebeau, Alizee, Hendrick, Elodie, Hubert, Pascale, Poncin, Aurelie, Penny, William, Piazzon, Nathalie, Monnien, Franck, Guenat, David, Mougin, Christiane, Prétet, Jean-Luc, Vuitton, Lucine, Segers, Karin, Lambert, Frederic, Bours, Vincent, de Leval, Laurence, Valmary-Degano, Severine, Quick, Charles M, Crum, Christopher P, Delvenne, Philippe
Publicado 2018

AZ304, a novel dual BRAF inhibitor, exerts anti-tumour effects in colorectal cancer independently of BRAF genetic status

por Ma, Rui, Xu, Ling, Qu, Xiujuan, Che, Xiaofang, Zhang, Ye, Fan, Yibo, Li, Ce, Guo, Tianshu, Hou, Kezuo, Hu, Xuejun, Drew, Lisa, Shen, Minhui, Cheung, Tony, Liu, Yunpeng
Publicado 2018

Prognostic value of isolated tumour cells in sentinel lymph nodes in early-stage breast cancer: a prospective study

por Liikanen, Jenni S., Leidenius, Marjut H., Joensuu, Heikki, Vironen, Jaana H., Meretoja, Tuomo J.
Publicado 2018